Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: po...
Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan
About this item
Full title
Author / Creator
Ikezoe, Takayuki , Noji, Hideyoshi , Ueda, Yasutaka , Kanda, Yoshinobu , Okamoto, Shinichiro , Usuki, Kensuke , Matsuda, Takahisa , Akiyama, Hirozumi , Shimono, Akihiko , Yonemura, Yuji , Kawaguchi, Tatsuya , Chiba, Shigeru , Kanakura, Yuzuru , Nishimura, Jun‑ichi , Ninomiya, Haruhiko and Obara, Naoshi
Publisher
Singapore: Springer Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Singapore
Subjects
More information
Scope and Contents
Contents
All Japanese patients with paroxysmal nocturnal hemoglobinuria (PNH) treated with eculizumab were enrolled in post-marketing surveillance (PMS) between June 2010 and August 2019 to assess the long-term effectiveness and safety of eculizumab. The reduction in intravascular hemolysis, the change in hemoglobin (Hb) level, and the change in renal funct...
Alternative Titles
Full title
Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2645319529
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2645319529
Other Identifiers
ISSN
0925-5710,1865-3774
E-ISSN
1865-3774
DOI
10.1007/s12185-022-03287-y
